Its core business is the development of high performance cell culture media for the life sciences economy, and for the biopharmaceutical industry in particular. At the basis of this venture is a technology developed at REQUIMTE, Chemistry Department, FCT/UNL, in the systems biology and engineering lab headed by Prof. Rui Oliveira. MediaOmics is the exclusive licensee of this technology.